FRULLANTI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 5.125
NA - Nord America 4.272
AS - Asia 731
SA - Sud America 92
AF - Africa 35
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.267
Nazione #
US - Stati Uniti d'America 4.247
IT - Italia 1.362
GB - Regno Unito 1.134
IE - Irlanda 722
DE - Germania 384
CN - Cina 318
RU - Federazione Russa 314
SE - Svezia 312
FR - Francia 308
SG - Singapore 212
UA - Ucraina 194
FI - Finlandia 174
BR - Brasile 75
VN - Vietnam 56
NL - Olanda 55
ES - Italia 43
IN - India 29
TR - Turchia 26
CI - Costa d'Avorio 24
BE - Belgio 22
IR - Iran 22
AT - Austria 20
CZ - Repubblica Ceca 20
CA - Canada 16
CH - Svizzera 12
HK - Hong Kong 11
PL - Polonia 8
AU - Australia 7
BG - Bulgaria 6
JM - Giamaica 5
PE - Perù 5
PH - Filippine 5
AR - Argentina 4
EU - Europa 4
JP - Giappone 4
MA - Marocco 4
MK - Macedonia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BD - Bangladesh 3
CL - Cile 3
CY - Cipro 3
DK - Danimarca 3
GE - Georgia 3
IL - Israele 3
LK - Sri Lanka 3
LT - Lituania 3
LV - Lettonia 3
NO - Norvegia 3
PT - Portogallo 3
TM - Turkmenistan 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
BY - Bielorussia 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
ID - Indonesia 2
KG - Kirghizistan 2
MY - Malesia 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
MD - Moldavia 1
MM - Myanmar 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
TH - Thailandia 1
Totale 10.267
Città #
Southend 1.019
Dublin 704
Fairfield 584
Chandler 406
Ashburn 374
Santa Clara 331
Siena 289
Woodbridge 272
Cambridge 220
Houston 209
Seattle 207
Wilmington 188
Ann Arbor 183
Milan 175
Jacksonville 154
Munich 135
Helsinki 134
Singapore 115
Princeton 94
New York 86
Florence 74
Beijing 71
Rome 64
Dong Ket 55
Nanjing 54
San Mateo 43
San Diego 42
Boardman 41
Dearborn 41
Lancaster 35
Moscow 33
Shanghai 32
Nuremberg 30
Los Angeles 28
Washington 28
Málaga 27
Abidjan 24
Menlo Park 24
Brescia 23
Lauterbourg 23
Padova 21
Fremont 20
Brussels 19
London 18
Aachen 17
Izmir 16
Bologna 15
Chicago 15
Shenyang 15
Portsmouth 13
Düsseldorf 12
Guangzhou 12
Hebei 12
Norwalk 12
Ferrara 11
Hyderabad 11
Jinan 11
Nanchang 11
Redwood City 11
Brno 10
Comun Nuovo 10
Naples 10
Phoenix 10
Pisa 10
Vienna 10
Tianjin 9
Carrara 8
Newark 8
Paris 8
Columbus 7
Dallas 7
Empoli 7
Napoli 7
Zurich 7
Anagni 6
Hong Kong 6
Prague 6
Sofia 6
Tehran 6
Venice 6
Zanjan 6
Zhengzhou 6
Amsterdam 5
Bolzano 5
Catanzaro 5
Council Bluffs 5
Espoo 5
Falls Church 5
Kunming 5
Loro Ciuffenna 5
Piscataway 5
São Paulo 5
Toronto 5
Camden 4
Casalecchio di Reno 4
Esslingen am Neckar 4
Fiesole 4
Genova 4
Hangzhou 4
Jiaxing 4
Totale 7.202
Nome #
MEIS2 gene is responsible for intellectual disability, cardiac defects and a distinct facial phenotype 358
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 308
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 269
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 257
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 225
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 222
Genetic mechanisms of critical illness in COVID-19 220
Potentially treatable disorder diagnosed post Mortem by exome analysis in a boy with respiratory distress 216
Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome 215
Exome sequencing coupled with mRNA analysis identifies NDUFAF6 as a Leigh gene 212
Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia 212
Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+/- patients and in foxg1+/- mice 211
Alport syndrome: impact of digenic inheritance in patients management 206
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 206
Analysis of the Phenotypes in the Rett Networked Database 191
Personalized therapy in a GRIN1 mutated girl with intellectual disability and epilepsy 182
null 182
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 182
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 176
Commentary: Potential links between hepadnavirus and bornavirus sequences in the host genome and cancer 170
Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma 168
A polygenic model with common variants may predict lung adenocarcinoma risk in humans 168
Multiple genetic loci modulate lung adenocarcinoma clinical staging 164
Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer 159
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases 155
Germline polymorphisms and survival of lung adenocarcinoma patients: A genome-wide study in two European patient series 155
Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients 155
Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue 154
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 153
Mapping the human genetic architecture of COVID-19 151
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 148
Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk 147
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung 147
A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A 146
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 146
Germline mutations in lung cancer and personalized medicine 143
AAV-mediated FOXG1 gene editing in human Rett primary cells 142
A first update on mapping the human genetic architecture of COVID-19 141
Mouse Pulmonary Adenoma Susceptibility 1 Locus Is an Expression QTL Modulating Kras-4A 138
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 137
Authors' reply: Comment to "Vinyl chloride exposure and cirrhosis: A systematic review and meta-analysis" 135
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 134
null 133
Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5 131
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 119
An explainable model of host genetic interactions linked to COVID-19 severity 114
Vinyl chloride exposure and cirrhosis: A systematic review and meta-analysis 114
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor 112
WES profiling of COVID-19 110
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 103
Riorganizzazione dell’attività di Genetica Medica relativa ai test genetici per malattie rare in ottica LEAN 102
A pilot study of next generation sequencing–liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel–Trenaunay syndrome 102
MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy 99
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 99
Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation 97
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 93
Clinical and molecular characterization of COVID-19 hospitalized patients 91
SELP Asp603Asn and severe thrombosis in COVID-19 males 83
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 78
The phenomenon of multidrug resistance in glioblastomas 74
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 74
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis 71
Private somatic mutations identified with liquid biopsy lead tumor progression in solid cancers 67
Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice 64
Whole-genome sequencing reveals host factors underlying critical COVID-19 57
Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era 56
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 55
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: a systematic review and meta-analysis 50
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 49
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells 48
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 46
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 45
Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide 43
Editorial: Pharmacogenetic landscape in human solid cancers. 33
Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review 31
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors 30
Liquid Biopsies 29
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 26
Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males 25
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity 25
Noninvasive Genetic Testing: Adhesive Patch-Based Skin Biopsy and Buccal Swab 25
Editorial: Lung adenocarcinoma: from genomics to immunotherapy 24
Correction: New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells 22
Editorial: Liquid biopsy and new omics technologies in vascular malformations 15
Editorial: Current trends and future perspectives about liquid biopsy 15
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility 12
The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis 7
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions 6
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 3
Totale 10.613
Categoria #
all - tutte 40.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 0 0 0 0 146 139 45 89
2020/20211.465 57 85 83 98 114 110 107 175 120 229 140 147
2021/20221.208 141 143 75 89 56 43 63 40 60 120 144 234
2022/20231.626 90 139 166 190 124 318 109 142 143 57 94 54
2023/20241.472 70 47 170 89 62 355 390 60 22 60 40 107
2024/20252.158 102 146 345 216 419 233 227 223 247 0 0 0
Totale 10.613